Emerging roles of RB family: New defense mechanisms against tumor progression

The retinoblastoma (RB) family of proteins, including RB1/p105, retinoblastoma‐like 1 (RBL1/p107), and retinoblastoma‐like 2 (RBL2/p130), is principally known for its central role on cell cycle regulation. The inactivation of RB proteins confers a growth advantage and underlies multiple types of tumors. Recently, it has been shown that RB proteins have other important roles, such as preservation of chromosomal stability, induction and maintenance of senescence and regulation of apoptosis, cellular differentiation, and angiogenesis. RB proteins are involved in many cellular pathways and act as transcriptional regulators able to bind several transcription factors, thus antagonizing or potentiating their functions. Furthermore, RB proteins might control the expression of specific target genes by recruiting chromatin remodeling enzymes. Although many efforts have been made to dissect the different functions of RB proteins, it remains still unclear which are necessary for cancer suppression and the role they play at distinct steps of carcinogenesis. Moreover, RB proteins can behave differently in various cell types or cell states. Elucidating the intricate RB protein network in regulating cell fate might provide the knowledge necessary to explain their potent tumor suppressor activity and to design novel therapeutic strategies. J. Cell. Physiol. 228: 525–535, 2013. © 2012 Wiley Periodicals, Inc.

[1]  A. Giordano,et al.  On the role of retinoblastoma family proteins in the establishment and maintenance of the epigenetic landscape , 2013, Journal of cellular physiology.

[2]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[3]  N. Dyson,et al.  RB: mitotic implications of a tumour suppressor , 2012, Nature Reviews Cancer.

[4]  V. Parnaik,et al.  Cyclin D3 promotes myogenic differentiation and Pax7 transcription , 2012, Journal of cellular biochemistry.

[5]  R. Benezra,et al.  Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. , 2011, Cancer cell.

[6]  B. Kerem,et al.  Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development , 2011, Cell.

[7]  E. Zacksenhaus,et al.  Critical Role of the Rb Family in Myoblast Survival and Fusion , 2011, PloS one.

[8]  A. Giordano,et al.  Retinoblastoma beyond RB1: recent advances in genetic biomarkers , 2010 .

[9]  D. Peeper,et al.  The essence of senescence. , 2010, Genes & development.

[10]  D. McCance,et al.  Acetylation of Rb by PCAF is required for nuclear localization and keratinocyte differentiation , 2010, Journal of Cell Science.

[11]  R. Banerjee,et al.  Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. , 2010, Genes & development.

[12]  N. Dyson,et al.  Loss of pRB causes centromere dysfunction and chromosomal instability. , 2010, Genes & development.

[13]  Michael Ruogu Zhang,et al.  Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence , 2022 .

[14]  H. Shehata,et al.  Detection of survivin protein in aqueous humor and serum of retinoblastoma patients and its clinical significance. , 2010, Clinical biochemistry.

[15]  F. Dick,et al.  A G1 Checkpoint Mediated by the Retinoblastoma Protein That Is Dispensable in Terminal Differentiation but Essential for Senescence , 2009, Molecular and Cellular Biology.

[16]  K. Wikenheiser-Brokamp,et al.  Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis. , 2009, Cancer research.

[17]  W. Deppert,et al.  Rb2/p130 is the dominating pocket protein in the p53–p21 DNA damage response pathway leading to senescence , 2009, Oncogene.

[18]  S. Kitajima,et al.  Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. , 2009, Cancer cell.

[19]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[20]  J. Sage,et al.  Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.

[21]  T. Corson,et al.  Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. , 2008, Human molecular genetics.

[22]  D. Peeper,et al.  Cellular senescence in vivo: a barrier to tumorigenesis. , 2008, Current opinion in cell biology.

[23]  A. Giordano,et al.  From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb‐E2F pathway , 2007, Journal of cellular biochemistry.

[24]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[25]  E. Knudsen,et al.  RB Loss Promotes Aberrant Ploidy by Deregulating Levels and Activity of DNA Replication Factors* , 2007, Journal of Biological Chemistry.

[26]  H. Saya,et al.  Mitogenic signalling and the p16INK4a–Rb pathway cooperate to enforce irreversible cellular senescence , 2006, Nature Cell Biology.

[27]  J. Padmanabhan,et al.  Rb function in the apoptosis and senescence of non-neuronal and neuronal cells: role in oncogenesis. , 2006, Current molecular medicine.

[28]  A. Di Leonardo,et al.  RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts , 2006, Molecular Cancer.

[29]  C. Simone,et al.  pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription , 2006, Oncogene.

[30]  G. Zupi,et al.  Involvement of RB gene family in tumor angiogenesis , 2006, Oncogene.

[31]  S. Skapek,et al.  Regulation of cell lineage specification by the retinoblastoma tumor suppressor , 2006, Oncogene.

[32]  P. Claudio,et al.  Cell cycle control and beyond: emerging roles for the retinoblastoma gene family , 2006, Oncogene.

[33]  W. Du,et al.  Retinoblastoma family genes , 2006, Oncogene.

[34]  A. Giordano,et al.  pRb2/p130: a new candidate for retinoblastoma tumor formation , 2006, Oncogene.

[35]  S. Chellappan,et al.  Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  O. Pereira-smith,et al.  Primary and Compensatory Roles for RB Family Members at Cell Cycle Gene Promoters That Are Deacetylated and Downregulated in Doxorubicin-Induced Senescence of Breast Cancer Cells , 2006, Molecular and Cellular Biology.

[37]  Wei Gu,et al.  p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.

[38]  W. Deppert,et al.  Cooperation between p53 and p130(Rb2) in induction of cellular senescence , 2006, Cell Death and Differentiation.

[39]  B. Wegiel,et al.  A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer , 2005, Oncogene.

[40]  S. Lowe,et al.  Senescence comes of age , 2005, Nature Medicine.

[41]  J. Dimario,et al.  Dynamic Transcriptional Regulatory Complexes, Including E2F4, p107, p130, and Sp1, Control Fibroblast Growth Factor Receptor 1 Gene Expression during Myogenesis* , 2005, Journal of Biological Chemistry.

[42]  G. Babcock,et al.  Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy. , 2005, Cancer research.

[43]  A. Iavarone,et al.  Id2 Mediates Tumor Initiation, Proliferation, and Angiogenesis in Rb Mutant Mice , 2005, Molecular and Cellular Biology.

[44]  R. Weinberg,et al.  The signals and pathways activating cellular senescence. , 2005, The international journal of biochemistry & cell biology.

[45]  O. Adegbola,et al.  Phosphorylated Retinoblastoma Protein Complexes with pp32 and Inhibits pp32-mediated Apoptosis* , 2005, Journal of Biological Chemistry.

[46]  D. Cobrinik Pocket proteins and cell cycle control , 2005, Oncogene.

[47]  M. Blasco,et al.  Role of Rb Family in the Epigenetic Definition of Chromatin , 2005, Cell cycle.

[48]  Manel Esteller,et al.  Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin , 2005, Nature Cell Biology.

[49]  S. Chellappan,et al.  Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors , 2005, Oncogene.

[50]  B. Brüne,et al.  Retinoblastoma susceptibility gene product pRB activates hypoxia-inducible factor-1 (HIF-1) , 2005, Oncogene.

[51]  Chiaki Takahashi,et al.  Genetic Interaction between Rb and K-ras in the Control of Differentiation and Tumor Suppression , 2004, Molecular and Cellular Biology.

[52]  M. P. Holloway,et al.  Aberrant Regulation of Survivin by the RB/E2F Family of Proteins* , 2004, Journal of Biological Chemistry.

[53]  W. Gerald,et al.  Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control , 2004, Nature.

[54]  Umberto Galderisi,et al.  Role of RB and RB2/P130 genes in marrow stromal stem cells plasticity , 2004, Journal of cellular physiology.

[55]  D. DiMaio,et al.  Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. , 2004, Cancer research.

[56]  D. Easton,et al.  Lifetime risks of common cancers among retinoblastoma survivors. , 2004, Journal of the National Cancer Institute.

[57]  S. Lowe,et al.  Executing Cell Senescence , 2004, Cell cycle.

[58]  B. Spike,et al.  New roles for the RB tumor suppressor protein. , 2004, Current opinion in genetics & development.

[59]  P. Krammer,et al.  Apoptosis in cancer--implications for therapy. , 2004, Seminars in oncology.

[60]  T. Jacks,et al.  Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry , 2003, Nature.

[61]  S. Lowe,et al.  Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.

[62]  S. Lowe,et al.  Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.

[63]  Jean Y. J. Wang,et al.  Coordinated regulation of life and death by RB , 2003, Nature Reviews Cancer.

[64]  C. Cinti,et al.  Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation. , 2002, Investigative ophthalmology & visual science.

[65]  Ramana V. Davuluri,et al.  Direct coupling of the cell cycle and cell death machinery by E2F , 2002, Nature Cell Biology.

[66]  Jean Y. J. Wang,et al.  Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb , 2002, Nature Cell Biology.

[67]  A. Giordano,et al.  The retinoblastoma family: twins or distant cousins? , 2002, Genome Biology.

[68]  K. Kristiansen,et al.  Deregulated MAPK Activity Prevents Adipocyte Differentiation of Fibroblasts Lacking the Retinoblastoma Protein* , 2002, The Journal of Biological Chemistry.

[69]  Phang-lang Chen,et al.  Deficiency of Retinoblastoma gene in mouse embryonic stem cells leads to genetic instability. , 2002, Cancer research.

[70]  Brigitte M Pützer,et al.  Gene expression changes in response to E2F1 activation. , 2002, Nucleic acids research.

[71]  J. Campisi,et al.  Cellular senescence, cancer and aging: the telomere connection , 2001, Experimental Gerontology.

[72]  L. Kedes,et al.  Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. , 2001, Molecular cell.

[73]  L. Hennighausen,et al.  Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene , 2001, Oncogene.

[74]  N. Berndt,et al.  Protein phosphatase 1α-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein , 2001, Oncogene.

[75]  M. Glozak,et al.  Retinoic acid- and bone morphogenetic protein 4-induced apoptosis in P19 embryonal carcinoma cells requires p27. , 2001, Experimental cell research.

[76]  W. C. Forrester,et al.  The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. , 2001, Molecular cell.

[77]  M. Krstic-Demonacos,et al.  Acetylation control of the retinoblastoma tumour-suppressor protein , 2001, Nature Cell Biology.

[78]  K. Helin,et al.  Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.

[79]  P. Hinds,et al.  Requirement for p27KIP1 in Retinoblastoma Protein-Mediated Senescence , 2001, Molecular and Cellular Biology.

[80]  R. Mamillapalli,et al.  PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2 , 2001, Current Biology.

[81]  A. V. van Rossum,et al.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. , 2000, Genes & development.

[82]  T. Jacks,et al.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. , 2000, Genes & development.

[83]  W. Sellers,et al.  Cells Degrade a Novel Inhibitor of Differentiation with E1A-Like Properties upon Exiting the Cell Cycle , 2000, Molecular and Cellular Biology.

[84]  B. Kennedy,et al.  Opposing roles of pRB and p107 in adipocyte differentiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[85]  P. Pearson,et al.  Atmospheric carbon dioxide concentrations over the past 60 million years , 2000, Nature.

[86]  S. Lowe,et al.  PML is induced by oncogenic ras and promotes premature senescence. , 2000, Genes & development.

[87]  Pier Paolo Pandolfi,et al.  PML regulates p53 acetylation and premature senescence induced by oncogenic Ras , 2000, Nature.

[88]  D. Riley,et al.  Retinoblastoma Protein Enhances the Fidelity of Chromosome Segregation Mediated by hsHec1p , 2000, Molecular and Cellular Biology.

[89]  P. Carmeliet,et al.  Molecular Basis of Angiogenesis: Role of VEGF and VE‐Cadherin , 2000, Annals of the New York Academy of Sciences.

[90]  R. Kolodner,et al.  Links between replication, recombination and genome instability in eukaryotes. , 2000, Trends in biochemical sciences.

[91]  M. Steiner,et al.  p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways , 2000, Oncogene.

[92]  R. DePinho,et al.  A critical role for telomeres in suppressing and facilitating carcinogenesis. , 2000, Current opinion in genetics & development.

[93]  R. Jessberger,et al.  Mammalian SMC3 C-terminal and Coiled-coil Protein Domains Specifically Bind Palindromic DNA, Do Not Block DNA Ends, and Prevent DNA Bending* , 1999, The Journal of Biological Chemistry.

[94]  M. Ewen,et al.  The Retinoblastoma Protein Is Linked to the Activation of Ras , 1999, Molecular and Cellular Biology.

[95]  S. Jacobsen,et al.  Involvement of the retinoblastoma protein in monocytic and neutrophilic lineage commitment of human bone marrow progenitor cells. , 1999, Blood.

[96]  H. Zhang,et al.  Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[97]  A. Lassar,et al.  pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation , 1999, Current Biology.

[98]  Xin Lu,et al.  RB regulates the stability and the apoptotic function of p53 via MDM2. , 1999, Molecular cell.

[99]  R. DePinho,et al.  The INK4A/ARF locus and its two gene products. , 1999, Current opinion in genetics & development.

[100]  X. Graña,et al.  Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth , 1998, Oncogene.

[101]  E. Gelmann,et al.  Radiation-induced apoptosis mediated by retinoblastoma protein. , 1998, Cancer research.

[102]  G. Mills,et al.  Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition , 1997, Oncogene.

[103]  M. Day,et al.  Cell Anchorage Regulates Apoptosis through the Retinoblastoma Tumor Suppressor/E2F Pathway* , 1997, The Journal of Biological Chemistry.

[104]  B. Gallie,et al.  pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. , 1996, Genes & development.

[105]  T. Jacks,et al.  Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle , 1996, The Journal of cell biology.

[106]  C. Kitanaka,et al.  Apoptosis in cancer. , 1996, Human cell.

[107]  R. Armitage,et al.  Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein. , 1996, Oncogene.

[108]  R. Weinberg,et al.  Shared role of the pRB-related p130 and p107 proteins in limb development. , 1996, Genes & development.

[109]  R. Gill,et al.  Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[110]  Q. Dou,et al.  Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[111]  S. Weintraub,et al.  Mechanism of active transcriptional repression by the retinoblastoma protein , 1995, Nature.

[112]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[113]  R. DePinho,et al.  p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens , 1994, Nature.

[114]  W. Gu,et al.  Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. , 1994, Science.

[115]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[116]  A. Bradley,et al.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.

[117]  D. Scott,et al.  Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[118]  E. Harlow,et al.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.

[119]  R. Weinberg,et al.  Point mutational inactivation of the retinoblastoma antioncogene. , 1989, Science.

[120]  J. Minna,et al.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. , 1988, Science.

[121]  W. Lee,et al.  Inactivation of the retinoblastoma susceptibility gene in human breast cancers. , 1988, Science.

[122]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[123]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[124]  S. Lowe,et al.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. , 2007, Cancer cell.

[125]  M. Crescenzi,et al.  pRb in the Differentiation of Normal and Neoplastic Cells , 2006 .

[126]  Adrian A Canutescu,et al.  Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. , 2005, Developmental cell.

[127]  P. Stiegler,et al.  RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. , 2001, Cancer research.

[128]  L. Hartwell,et al.  Cell cycle checkpoints, genomic integrity, and cancer. , 1994, Cold Spring Harbor symposia on quantitative biology.

[129]  J Salvage,et al.  A matter of life and death. , 1981, Nursing times.